News and Announcements
Released ASX Announcement: Simble Signs Three Year Agreement With Sylvania Lighting
- Published February 21, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
SIMBLE SIGNS THREE YEAR AGREEMENT WITH SYLVANIA LIGHTING
21 February 2020 – Simble Solutions Limited (ASX: SIS) has signed a three-year agreement with Sylvania Lighting to incorporate the Simble Sense Platform into lighting projects to commercial customers, commencing in the UK, France Germany, Spain and Italy.
Read the full article here.
About Simble Solutions Limited
Simble Solutions Limited (ASX: SIS) (Simble or the Company), an Australian software company focused on energy Software-as-a-Service (SaaS) and Internet of Things (IoT) solutions, is pleased to announce that Wattwatchers Digital Energy (Wattwatchers), a manufacturer of energy meters, has appointed Simble as the first certified third-party app provider as part of a national roll-out of smart energy technology to homes, businesses and schools, partly funded by the Australian Government’s Australian Renewable Energy Agency (ARENA).
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
